source
- Grace Science warns FDA bottleneck threatens ultra-rare gene therapy progressGrace Science, a biotech focused on ultra-rare diseases, has been developing a gene-therapy candidate that appeared close to regulatory approval. The company, co-founded by Nobel laureate Carolyn…
- Garner Health secures $100 million funding, valuation climbs to $2.7 billionGarner Health announced a $100 million financing round that pushes its post‑money valuation to $2.7 billion. The capital raise was completed last month and was led by a group of venture investors.…